Beckie Fenrick

Chief Pharmacy Officer

Beckie Fenrick

The Cost Implications of New Weight Loss Treatments for Plan Sponsors

See this article by AlignRx chief pharmacy officer Beckie Fenrick as it originally appeared in BenefitsPRO. With obesity rates in the United States having tripled since the 1980s, the health care system now faces an annual cost of $173 billion due to obesity-related complications, such as heart disease, hypertension, joint pain and certain types of …

The Cost Implications of New Weight Loss Treatments for Plan Sponsors Read More »

What Brokers and TPAs Need To Know About Humira Biosimilars

Below is an excerpt from an article by AlignRx chief pharmacy officer Beckie Fenrick and Goodroot area vice president of business development Brian Shonat that was recently published in BenefitsPRO. Following decades of patent litigation and maneuvering, the first biosimilar to Humira is now available with many more to follow this year. Humira is a …

What Brokers and TPAs Need To Know About Humira Biosimilars Read More »

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars

The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be a test for industry stakeholders, as their entrance will reveal whether blockbuster drugs—that offer significant rebates—can be replaced to reduce the cost burden on patients and payers in the United States. Download our …

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars Read More »

Prediabetes and Type 2 Diabetes Screening

What is happening:  In August 2021 the United States Preventive Services Task Force (USPSTF) recommended that adults, aged 35 to 70 years who are overweight or obese, be screened for prediabetes or type 2 diabetes. In addition to these screenings, USPSTF recommended that clinicians should offer patients with prediabetes effective preventive interventions. Preventive interventions include …

Prediabetes and Type 2 Diabetes Screening Read More »

What Employers, TPAs and Brokers Need to Know About COVID 10 Home Testing

January 10, 2022, the U.S. Department of Labor (DOL) issued guidance related to insurance coverage for COVID OTC testing, provided at no cost to covered individuals that was effective as of January 15, 2022. COVID 10 Home Testing Highlights Beginning January 15, 2022, most individuals with health insurance can purchase at home over-the-counter COVID-19 diagnostic …

What Employers, TPAs and Brokers Need to Know About COVID 10 Home Testing Read More »

How Digital Therapeutics Are Paid For Has Huge Implications

Digital Therapeutics (DTx) have been increasingly popular since smartphones and wearable tech have become ubiquitous. The pandemic has set them on a trajectory for massive growth and mainstream adoption. Currently, there is inconsistency in how DTx are handled by payers and health plans. We are at a critical juncture to set precedents that make sense …

How Digital Therapeutics Are Paid For Has Huge Implications Read More »